Candidal mediastinitis is rare. We report nine cases encountered at our institutions since 1985; seven cases were diagnosed since 1993. All cases followed thoracic surgery, with a median time from surgery to disease onset of 11 days (range, 6 -100 days). All patients received prior antibiotic therapy. Common clinical manifestations were chest wall erythema in 4 cases (44%), drainage in 5 (56%), fever in 4 (44%), and sternal instability in 4 (44%). Failure to obtain appropriate intraoperative specimens for cultures and the dismissal of cultures positive for Candida as contaminants delayed diagnosis in three cases (33%). Mediastinitis was complicated by contiguous or hematogenous spread in seven cases (78%); five patients (56%) had two or more complications. The mortality rate was 56%. Optimal therapy remains undefined, but on the basis of our experience, aggressive surgical debridement combined with antifungal therapy for at least 6 weeks is recommended. Prompt recognition and institution of therapy appear to be the keys to improving prognosis. Candida is a rare cause of mediastinitis, causing only 5%
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1985 and 1996 were identified via infection control files and medical record discharge code. Chart reviews determined that of cases reported in the English-language literature [1 -13] . Although an increase in individual case reports of candidal eight cases fulfilled our criteria for candidal mediastinitis (see under Inclusion Criteria). An additional case meeting the critemediastinitis has appeared in the literature since 1990 [14 -17] , the understanding of the disease and its optimal manageria was identified in a prospective study of candidemia that we conducted [18] . ment remain limited by the small number of reported cases, the lack of a consistent definition of mediastinitis, incomplete
We also reviewed the previously reported cases of candidal mediastinitis in the English-language literature from 1966 to clinical descriptions and accounts of therapy, and inadequate long-term follow-up of patients. Given the high morbidity and 1996 by using MEDLINE. Key words used were Candida, fungus, mediastinitis, pericarditis, sternal, and osteomyelitis. mortality rates associated with candidal mediastinitis [14] , a comprehensive review of the clinical manifestations, natural history, microbiology, therapy, and outcome of the disease is Inclusion Criteria needed.
Our experience with five cases of candidal mediastinitis from Cases in our series met the following criteria: mediastinitis -1995 to 1996 prompted us to conduct such a review. A search infection of the region within the thorax between the pleural for all cases at our institutions since 1985 confirmed the impressacs that is bounded inferiorly by the diaphragm, superiorly by sion of its increasing incidence: of nine cases identified, 78% the aperture of thorax, anteriorly by the sternum and costal were diagnosed since 1993. In addition, we identified seven cartilages, and posteriorly by the thoracic vertebrae [19] ; and cases previously reported in the English-language literature that Candida-positive culture of a specimen obtained intraoperafulfilled our rigorous definition of candidal mediastinitis (see tively or by guided biopsy from within the mediastinum. under Methods). We present our series of nine cases and review Superficial wound infections following median sternotomy the literature to provide more complete insight into this emergor thoracotomy were excluded, as were cases of sternal osteoing clinical entity. myelitis, endocarditis, pericarditis, or empyema without evidence of extension into the mediastinum. NOTE. In case 9, the patient was infected with Candida glabrata. All other patients were infected with Candida albicans. CABG Å coronary artery bypass grafting; S/P Å status post; VSD Å ventricular septal defect.
Methods

Results
Potential
Patient Demographics and Underlying Conditions
received antibacterial agents postoperatively. Three (33%) of nine patients were also treated with antibacterial agents for at In our series, there were six adults and three children. Two least 4 days prior to surgery; all of these patients developed of the children were newborn infants. All three children had mediastinitis shortly after surgery. congenital heart disease; two children underwent a BlalockTaussig shunt procedure, and the third underwent orthotopic heart transplantation. In the six adults, the most common underlying diseases (in descending order) were coronary ar-
Clinical Manifestations
tery disease (3 patients), valvular heart disease (2), and malignancy (1).
The most common clinical manifestation was purulent drainage from the sternum (56%) (table 1). Fever, sternal All nine patients underwent thoracic surgery prior to the development of mediastinitis. The median time between surinstability, and chest wall erythema were each noted in 44% of patients. Other manifestations included shock (33% of pagery and the onset of mediastinitis was 11 days (range, 6 -100 days). Of note, the onset of mediastinitis in eight (89%) of tients), sternal click (22%), respiratory distress (11%), subcutaneous emphysema (secondary to esophageal rupture; 11%), nine patients occurred within 28 days of surgery; the onset occurred within 14 days in six (69%) of nine. All patients wound dehiscence (11%), and sternal tenderness (11%).
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Microbiology
this delay was due to failure to obtain appropriate intraoperative specimens for culture (patients 1 and 5) or dismissal of cultures All patients except one were infected with Candida albicans; positive for Candida as contaminants (patient 8). one patient was infected with Candida glabrata. For eight (89%) of nine patients, Candida was isolated in pure culture. Cultures of specimens from within the mediastinum of all paComplications tients were positive for Candida. Other positive culture speciMediastinitis was complicated by either contiguous or hemamens included blood (44% of cases), sternal bone (44%), pleutogenous spread in seven (78%) of nine patients. Five (56%) ral fluid (22%), pericardial fluid (22%), urine (22%), thrombus of nine patients had two or more complications. Complications (22%), wound site (11%), and hardware (11%). One patient included fungemia (44% of patients), sternal osteomyelitis had prior bacteremia, and another had concomitant bacterial (44%), empyema (22%), pericarditis (22%), peritonitis (11%), infections of the mediastinum (table 1) . chronic wound infection (11%), and infected thrombus (22%).
Diagnosis Outcome and Therapy
All patients had clinical evidence of mediastinitis. The diagnosis was subsequently confirmed by cultures positive for Can-
The overall mortality rate was 56%; four (80%) of five deaths were directly attributable to candidal mediastinitis (tables 2 dida. Chest radiographs were suggestive of mediastinitis in six (75%) of eight cases; these radiographs demonstrated a mass and 3). Six patients were treated with combined surgical debrideor fluid collection in four cases and mediastinal air in two.
For three patients, the diagnosis of candidal infection was ment and antifungal agents. Three of these patients died: two received amphotericin B therapy (patients 2 and 3) and one not made until at least 3 weeks after the onset of mediastinitis; / 9c37$$se47 08-19-97 12:10:08 cida UC: CID cases followed thoracic surgery, which has been identified as the major predisposing factor for mediastinitis. In the era before cardiothoracic surgery, perforation of the esophagus was the leading cause of mediastinitis. In our series, only one patient received fluconazole therapy (patient 4). All three patients had multiple complications of candidal mediastinitis: fungemia (2 developed candidal mediastinitis as a complication of an esophageal leak. patients), pericarditis (2), sternal osteomyelitis (2), empyema (2), and peritonitis (1). The three surviving patients were treated All our patients received antibacterial agents postoperativley; three (33%) of nine patients also received antibacterial therapy with fluconazole alone (one patient) or with amphotericin B for 2 weeks followed by fluconazole for at least 6 weeks for at least 4 days immediately prior to surgery. Prior receipt of antibacterial agents has been well established to be associ-(two patients). These patients were doing well at 9-, 7-, and 14-month follow-ups, respectively. ated with candidemia and with nosocomial infection due to Candida. Two patients who were treated with surgical debridement alone either died (patient 1) or developed chronic infection that One of the most surprising findings in our series was that six (67%) of nine cases occurred relatively early (within 14 ultimately required therapy with an antifungal agent (patient 8). The diagnosis was delayed for both patients: for patient 1, days) after surgery. These observations suggest that the portal of entry is often direct intraoperative inoculation; indeed, direct appropriate specimens for culture were not obtained during the initial surgery, and for patient 8, cultures positive for Candida inoculation was the attributed portal of entry in all patients in our series and in 15 (94%) of all 16 cases reviewed. were dismissed as contaminants.
One patient who was treated with antifungal therapy alone The most common clinical manifestations of candidal mediastinitis were chest wall drainage, erythema, sternal instability, died despite treatment with liposomal amphotericin B and flucytosine (patient 9). fever, and shock. These findings were indistinguishable from those of bacterial mediastinitis. As such, Candida should be considered as a possible etiologic agent in any case of mediastinitis, especially those cases occurring in the setting of prior Discussion use of broad-spectrum antibiotics or those that do not respond to surgical debridement and therapy with antibacterial agents. Candidal mediastinitis is a rare clinical entity. The largest review of candidal mediastinitis, published in 1990, included An appropriate level of suspicion is crucial to early diagnosis. All debrided or aspirated material should be sent for micro-39 cases previously reported in the English-language literature [14] . Many of these cases, however, were superficial wound biological and histopathologic studies. The failure to appropriately obtain culture specimens from patients or the dismissal infections following sternotomy or infections of the sternum, costal cartilages, heart, pericardium, or pleura rather than true of cultures positive for Candida as contaminants led to delay in diagnosis in three (33%) of our nine cases; all of these infections involving the mediastinum [20 -27] . In addition, several reports failed to adequately provide clinical details, localize patients died or subsequently developed chronic infections requiring multiple debridements and long-term antifungal the precise site of infection, describe the method for diagnosis, or offer compelling evidence that Candida was contributing to therapy.
The mortality rate of 56% in our series was similar to that disease [6, 7, 9, 14, 28 -36] . We could identify only seven reports published since 1966 that provided a complete case of 43% in the previous case reports. In our series, four (80%) of five patients with multiple (at least two) complications of description of a well-documented diagnosis of candidal mediastinitis [14 -17, 37 -40] (table 4) . To this body of experience, candidal mediastinitis died; one (25%) of four with no or only one complication died. All survivors in our series and the prewe add our series of nine cases.
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08-19-97 12:10:08 cida UC: CID viously reported cases had significant morbidity, with procombining surgical and antifungal treatment appear to be the most important determinants of satisfactory outcome. longed hospitalizations, repeated debridements, and clinical relapses.
It is important to stress that the follow-ups in several preConclusions viously reported cases were relatively short; therefore, any reports of cure must be interpreted with caution. It is not uncomIncreased recognition of Candida species as causes of bloodmon for apparently healed sternal wounds, in particular, to stream infection has been paralleled by increased appreciation recrudesce months after cessation of therapy. As an example, of the role of these organisms in other nosocomial infectious a 42-year-old man with candidal mediastinitis associated with processes. Candidal mediastinitis is one such process that has pericarditis and sternal osteomyelitis was described as cured recently emerged as a significant cause of mortality and morat a 9-month follow-up after two therapeutic courses of amphobidity, particularly in patients undergoing thoracic surgery. tericin B and aggressive surgical debridement [40] . A subseThis entity should be suspected in any patient with infection quent report noted that 16 months later, his sternal wound of the mediastinum, especially those cases occurring in the infection recurred, and further therapy was required [14] .
setting of broad-spectrum antibiotic use or those that do not Evaluation of the optimal therapy for candidal mediastinitis respond to aggressive surgical debridement and therapy with is limited by shortcomings in the literature, particularly incomantibacterial agents. It is of paramount importance that approplete descriptions of antifungal regimens. On the basis of our priate samples from any patient with suspected mediastinitis experience, however, therapy combining aggressive surgical be sent for microbiological and histopathologic studies. Delay debridement with antifungal agents is the preferred approach in diagnosis has been associated with poor outcome, including to management of these infections. Early diagnosis offers the chronic wound infection, local extension involving the pericarbest chance to reduce subsequent morbidity and mortality. Vasdium, pleural sac, and sternal bone, and hematogenous seeding. cular flaps have been touted as essential for cure [14] , but Mediastinitis complicated by these processes often is associated with a fatal prognosis. The optimal therapy for candidal mediin our experience, prompt diagnosis and aggressive therapy / 9c37$$se47 
